tirzepatide for children π¨ Diabetes News Update Families π¨ Big update in pediatric diabetes care π Mounjaro (tirzepatide) is now approved for and adolescents ages 10 and older with type 2 diabetes. This Eli Lilly's Tirzepatide Shows Promise
Description
Can peptides help with the loose skin from rapid weight loss
While tirzepatide produces weight loss independent of exercise, sedentary patients generally achieve less favorable body composition changes and may experience slower metabolic improvements
The peptide degrades rapidly at room temperature
Tirzepatide is a GLP-1/GIP receptor agonist that has been studied in FDA-approved medications such as Mounjaro
This variability makes consistent dosing difficult even under ideal conditions
[DOI] [PMC free article] [PubMed] [Google Scholar] 24.Budd J., Cusi K
